INT328199

From wiki-pain
Revision as of 09:48, 22 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.04
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (CSF3) extracellular region (CSF3) enzyme binding (CSF3)
CSF3 (Homo sapiens)
Pain Link Frequency Relevance Heat
headache 4 6.32 Low Low
Paracetamol 4 5.00 Very Low Very Low Very Low
backache 4 5.00 Very Low Very Low Very Low
Angina 2 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cv Unclassified Under Development 2 44.24 Quite Low
Congenital Anomalies 6 33.80 Quite Low
Muscular Spasm 2 9.52 Low Low
Headache 4 6.32 Low Low
Low Back Pain 4 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
Nicotine Addiction 2 5.00 Very Low Very Low Very Low
Body Weight 2 5.00 Very Low Very Low Very Low
Breast Cancer 2 5.00 Very Low Very Low Very Low
Angina 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
PK analyses largely supported the bioequivalence of Hospira filgrastim and Amgen filgrastim.
Negative_regulation (supported) of Positive_regulation (bioequivalence) of filgrastim
1) Confidence 0.04 Published 2010 Journal Ann Hematol Section Body Doc Link PMC2924967 Disease Relevance 0 Pain Relevance 0
PK analyses largely supported the bioequivalence of Hospira filgrastim and Amgen filgrastim.
Negative_regulation (supported) of Positive_regulation (bioequivalence) of filgrastim
2) Confidence 0.04 Published 2010 Journal Ann Hematol Section Body Doc Link PMC2924967 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox